Global Pharmaceutical Excipients for Peptide Drug Synthesis Market Growth 2025-2031

Publication ID:

LPI07254823

Publication Date:

July 24, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Pharmaceutical Excipients for Peptide Drug Synthesis market size is predicted to grow from US$ 1881 million in 2025 to US$ 2820 million in 2031; it is expected to grow at a CAGR of 7.0% from 2025 to 2031.
Pharmaceutical Excipients for Peptide Drug Synthesis refer to inactive ingredients used in the research and production of peptide drugs to enhance solubility, stability, bioavailability, or delivery efficiency. These excipients include buffers, solvents, surfactants, antioxidants, chelating agents, and lyoprotectants, which help optimize the synthesis environment, improve product purity and yield, and extend the shelf life of the final formulation. With the rapid advancement of the biopharmaceutical industry, high-purity and highly stable excipients are playing an increasingly vital role in peptide drug manufacturing, driving continuous growth in the excipients market.
United States market for Pharmaceutical Excipients for Peptide Drug Synthesis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Pharmaceutical Excipients for Peptide Drug Synthesis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Pharmaceutical Excipients for Peptide Drug Synthesis is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Pharmaceutical Excipients for Peptide Drug Synthesis players cover Hunan Er-kang Pharmaceutical, Livzon Pharmaceutical, Anhui Sunhere Pharmaceutical Excipients, Merck, Suzhou Highfine Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淧harmaceutical Excipients for Peptide Drug Synthesis Industry Forecast鈥� looks at past sales and reviews total world Pharmaceutical Excipients for Peptide Drug Synthesis sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients for Peptide Drug Synthesis sales for 2025 through 2031. With Pharmaceutical Excipients for Peptide Drug Synthesis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients for Peptide Drug Synthesis industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients for Peptide Drug Synthesis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients for Peptide Drug Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Pharmaceutical Excipients for Peptide Drug Synthesis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients for Peptide Drug Synthesis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients for Peptide Drug Synthesis.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients for Peptide Drug Synthesis market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Buffers
Antioxidants
Surfactants
Others
Segmentation by Application:
Tumors
Metabolic Diseases
Cardiovascular
Orthopedics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Hunan Er-kang Pharmaceutical
Livzon Pharmaceutical
Anhui Sunhere Pharmaceutical Excipients
Merck
Suzhou Highfine Biotech
Kingchem
BroadPharm
Lubrizol Life Science
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Excipients for Peptide Drug Synthesis market?
What factors are driving Pharmaceutical Excipients for Peptide Drug Synthesis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Excipients for Peptide Drug Synthesis market opportunities vary by end market size?
How does Pharmaceutical Excipients for Peptide Drug Synthesis break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Pharmaceutical Excipients for Peptide Drug Synthesis by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Pharmaceutical Excipients for Peptide Drug Synthesis by Country/Region, 2020, 2024 & 2031
2.2 Pharmaceutical Excipients for Peptide Drug Synthesis Segment by Type
2.2.1 Buffers
2.2.2 Antioxidants
2.2.3 Surfactants
2.2.4 Others
2.3 Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Type
2.3.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Sales Market Share by Type (2020-2025)
2.3.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Revenue and Market Share by Type (2020-2025)
2.3.3 Global Pharmaceutical Excipients for Peptide Drug Synthesis Sale Price by Type (2020-2025)
2.4 Pharmaceutical Excipients for Peptide Drug Synthesis Segment by Application
2.4.1 Tumors
2.4.2 Metabolic Diseases
2.4.3 Cardiovascular
2.4.4 Orthopedics
2.4.5 Others
2.5 Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Application
2.5.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Sale Market Share by Application (2020-2025)
2.5.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Revenue and Market Share by Application (2020-2025)
2.5.3 Global Pharmaceutical Excipients for Peptide Drug Synthesis Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Breakdown Data by Company
3.1.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Sales by Company (2020-2025)
3.1.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Sales Market Share by Company (2020-2025)
3.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Revenue by Company (2020-2025)
3.2.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Revenue by Company (2020-2025)
3.2.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Revenue Market Share by Company (2020-2025)
3.3 Global Pharmaceutical Excipients for Peptide Drug Synthesis Sale Price by Company
3.4 Key Manufacturers Pharmaceutical Excipients for Peptide Drug Synthesis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pharmaceutical Excipients for Peptide Drug Synthesis Product Location Distribution
3.4.2 Players Pharmaceutical Excipients for Peptide Drug Synthesis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Pharmaceutical Excipients for Peptide Drug Synthesis by Geographic Region
4.1 World Historic Pharmaceutical Excipients for Peptide Drug Synthesis Market Size by Geographic Region (2020-2025)
4.1.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Pharmaceutical Excipients for Peptide Drug Synthesis Market Size by Country/Region (2020-2025)
4.2.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Sales by Country/Region (2020-2025)
4.2.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Revenue by Country/Region (2020-2025)
4.3 Americas Pharmaceutical Excipients for Peptide Drug Synthesis Sales Growth
4.4 APAC Pharmaceutical Excipients for Peptide Drug Synthesis Sales Growth
4.5 Europe Pharmaceutical Excipients for Peptide Drug Synthesis Sales Growth
4.6 Middle East & Africa Pharmaceutical Excipients for Peptide Drug Synthesis Sales Growth
5 Americas
5.1 Americas Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Country
5.1.1 Americas Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Country (2020-2025)
5.1.2 Americas Pharmaceutical Excipients for Peptide Drug Synthesis Revenue by Country (2020-2025)
5.2 Americas Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Type (2020-2025)
5.3 Americas Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Region
6.1.1 APAC Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Region (2020-2025)
6.1.2 APAC Pharmaceutical Excipients for Peptide Drug Synthesis Revenue by Region (2020-2025)
6.2 APAC Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Type (2020-2025)
6.3 APAC Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pharmaceutical Excipients for Peptide Drug Synthesis by Country
7.1.1 Europe Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Country (2020-2025)
7.1.2 Europe Pharmaceutical Excipients for Peptide Drug Synthesis Revenue by Country (2020-2025)
7.2 Europe Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Type (2020-2025)
7.3 Europe Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pharmaceutical Excipients for Peptide Drug Synthesis by Country
8.1.1 Middle East & Africa Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Country (2020-2025)
8.1.2 Middle East & Africa Pharmaceutical Excipients for Peptide Drug Synthesis Revenue by Country (2020-2025)
8.2 Middle East & Africa Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Type (2020-2025)
8.3 Middle East & Africa Pharmaceutical Excipients for Peptide Drug Synthesis Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients for Peptide Drug Synthesis
10.3 Manufacturing Process Analysis of Pharmaceutical Excipients for Peptide Drug Synthesis
10.4 Industry Chain Structure of Pharmaceutical Excipients for Peptide Drug Synthesis
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pharmaceutical Excipients for Peptide Drug Synthesis Distributors
11.3 Pharmaceutical Excipients for Peptide Drug Synthesis Customer
12 World Forecast Review for Pharmaceutical Excipients for Peptide Drug Synthesis by Geographic Region
12.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Market Size Forecast by Region
12.1.1 Global Pharmaceutical Excipients for Peptide Drug Synthesis Forecast by Region (2026-2031)
12.1.2 Global Pharmaceutical Excipients for Peptide Drug Synthesis Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Pharmaceutical Excipients for Peptide Drug Synthesis Forecast by Type (2026-2031)
12.7 Global Pharmaceutical Excipients for Peptide Drug Synthesis Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Hunan Er-kang Pharmaceutical
13.1.1 Hunan Er-kang Pharmaceutical Company Information
13.1.2 Hunan Er-kang Pharmaceutical Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.1.3 Hunan Er-kang Pharmaceutical Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Hunan Er-kang Pharmaceutical Main Business Overview
13.1.5 Hunan Er-kang Pharmaceutical Latest Developments
13.2 Livzon Pharmaceutical
13.2.1 Livzon Pharmaceutical Company Information
13.2.2 Livzon Pharmaceutical Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.2.3 Livzon Pharmaceutical Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Livzon Pharmaceutical Main Business Overview
13.2.5 Livzon Pharmaceutical Latest Developments
13.3 Anhui Sunhere Pharmaceutical Excipients
13.3.1 Anhui Sunhere Pharmaceutical Excipients Company Information
13.3.2 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.3.3 Anhui Sunhere Pharmaceutical Excipients Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Anhui Sunhere Pharmaceutical Excipients Main Business Overview
13.3.5 Anhui Sunhere Pharmaceutical Excipients Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.4.3 Merck Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Suzhou Highfine Biotech
13.5.1 Suzhou Highfine Biotech Company Information
13.5.2 Suzhou Highfine Biotech Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.5.3 Suzhou Highfine Biotech Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Suzhou Highfine Biotech Main Business Overview
13.5.5 Suzhou Highfine Biotech Latest Developments
13.6 Kingchem
13.6.1 Kingchem Company Information
13.6.2 Kingchem Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.6.3 Kingchem Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Kingchem Main Business Overview
13.6.5 Kingchem Latest Developments
13.7 BroadPharm
13.7.1 BroadPharm Company Information
13.7.2 BroadPharm Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.7.3 BroadPharm Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 BroadPharm Main Business Overview
13.7.5 BroadPharm Latest Developments
13.8 Lubrizol Life Science
13.8.1 Lubrizol Life Science Company Information
13.8.2 Lubrizol Life Science Pharmaceutical Excipients for Peptide Drug Synthesis Product Portfolios and Specifications
13.8.3 Lubrizol Life Science Pharmaceutical Excipients for Peptide Drug Synthesis Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Lubrizol Life Science Main Business Overview
13.8.5 Lubrizol Life Science Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂